Sophie B.
- Country
- France
- Department
- Haematology
Research Overview
- TRANSCRIPT: An open label, controlled, randomized multicentric international study evaluating the benefit of autologous stem cell transplantation after complete response in frontline setting patients with T cell-lymphoma
- Phase II Open-Label Study on Lenalidomide, Tafasitamab, and Rituximab in Frontline Diffuse Large B-Cell Lymphoma in Patients Aged 80 and Older
- Efficacy and Safety of Golcadomide with R-CHOP Versus Placebo with R-CHOP in High-risk Large B-cell Lymphoma: A Phase 3 Randomized Controlled Trial
Data & Insights
Has run more than one trial at 196 of 387 partner sites.
Specializations
B-Cell Lymphoma Research
This investigator specializes in diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma treatment approaches, with particular focus on novel therapeutic combinations.
- Novel antibody therapies including epcoritamab and mosunetuzumab
- Combination strategies with lenalidomide
- Treatment protocols for elderly DLBCL patients
Advanced work in high-risk and refractory B-cell lymphoma conditions, exploring innovative therapeutic pathways.
T-Cell Lymphoma Studies
Expertise in treating peripheral T-cell lymphoma (PTCL) and related conditions, with focus on transplantation outcomes and novel therapeutic approaches.
- Autologous stem cell transplantation efficacy
- KIR3DL2-positive PTCL treatments
- Combination therapy approaches
Investigation of targeted therapies for various T-cell lymphoma subtypes including AITL and ALCL.
Specialized Lymphoma Research
Focus on unique lymphoma presentations including primary central nervous system lymphoma and Richter's syndrome.
- Marginal zone lymphoma treatments
- CLL transformation studies
- Novel therapeutic combinations for rare lymphomas
Development of targeted approaches for specific lymphoma subtypes and transformations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.